Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cervical cancer
MedTech
BD to study HPV self-collection in underserved Texas communities
BD’s HPV test received an FDA approval in May, alongside a test developed by Roche, that allows women to skip the traditional Pap smear exam.
Conor Hale
Nov 21, 2024 10:45am
Transgene's viral cancer vaccine flunks midphase test
Oct 14, 2024 4:59am
FDA approves self-collection screening for HPV, cervical cancer
May 15, 2024 11:03am
Barinthus HPV drug doesn't prove efficacy
Apr 19, 2024 9:50am
Hologic harnesses FDA nod for AI-powered Pap test analysis
Feb 2, 2024 10:08am
BD taps Techcyte to bring AI to Pap smear tests
Jan 31, 2024 11:58am
